The Scottish Medicines Consortium (SMC) provides advice to NHS Scotland about the value for patients of newly licensed medicines. The SMC reviews new medicines that have received a licence from the Medicines and Healthcare products Regulatory Agency (MHRA – the licensing body for the UK). They also review new formulations of, and new ways to use, established medicines. Before a medicine can be prescribed routinely in Scotland, it has to be accepted for use by SMC.
